177 related articles for article (PubMed ID: 24855353)
61. Inhibition of folic acid uptake by catechins and tea extracts in Caco-2 cells.
Alemdaroglu NC; Wolffram S; Boissel JP; Closs E; Spahn-Langguth H; Langguth P
Planta Med; 2007 Jan; 73(1):27-32. PubMed ID: 17117344
[TBL] [Abstract][Full Text] [Related]
62. Differentiated Caco-2 cell monolayers exhibit adaptation in the transport and metabolism of flavan-3-ols with chronic exposure to both isolated flavan-3-ols and enriched extracts.
Redan BW; Chegeni M; Ferruzzi MG
Food Funct; 2017 Jan; 8(1):111-121. PubMed ID: 27808339
[TBL] [Abstract][Full Text] [Related]
63. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
[TBL] [Abstract][Full Text] [Related]
64. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
65. Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection.
Cheng CY; Barro L; Tsai ST; Feng TW; Wu XY; Chao CW; Yu RS; Chin TY; Hsieh MF
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809762
[TBL] [Abstract][Full Text] [Related]
66. Metabolic Activity of Anthocyanin Extracts Loaded into Non-ionic Niosomes in Diet-Induced Obese Mice.
Colorado D; Fernandez M; Orozco J; Lopera Y; Muñoz DL; Acín S; Balcazar N
Pharm Res; 2020 Jul; 37(8):152. PubMed ID: 32700034
[TBL] [Abstract][Full Text] [Related]
67. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
68. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
69. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
70. Combinational enhancing effects of formulation and encapsulation on digestive stability and intestinal transport of green tea catechins.
Son YR; Chung JH; Ko S; Shim SM
J Microencapsul; 2016; 33(2):183-90. PubMed ID: 26878684
[TBL] [Abstract][Full Text] [Related]
71. Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (-)epigallocatechin-3-gallate from green tea extract: a human study.
Gawande S; Kale A; Kotwal S
Phytother Res; 2008 Jun; 22(6):802-8. PubMed ID: 18446840
[TBL] [Abstract][Full Text] [Related]
72. Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models.
Zhou W; Di LQ; Wang J; Shan JJ; Liu SJ; Ju WZ; Cai BC
Acta Pharmacol Sin; 2012 Aug; 33(8):1069-79. PubMed ID: 22773077
[TBL] [Abstract][Full Text] [Related]
73. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
[TBL] [Abstract][Full Text] [Related]
74. Effects of co-administration of tea epigallocatechin-3-gallate (EGCG) and caffeine on absorption and metabolism of EGCG in humans.
Nakagawa K; Nakayama K; Nakamura M; Sookwong P; Tsuduki T; Niino H; Kimura F; Miyazawa T
Biosci Biotechnol Biochem; 2009 Sep; 73(9):2014-7. PubMed ID: 19734672
[TBL] [Abstract][Full Text] [Related]
75. The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
Thwala LN; Beloqui A; Csaba NS; González-Touceda D; Tovar S; Dieguez C; Alonso MJ; Préat V
J Control Release; 2016 Dec; 243():109-120. PubMed ID: 27720993
[TBL] [Abstract][Full Text] [Related]
76. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
Nakagawa K; Miyazawa T
J Nutr Sci Vitaminol (Tokyo); 1997 Dec; 43(6):679-84. PubMed ID: 9530620
[TBL] [Abstract][Full Text] [Related]
77. Sustained release of epigallocatechin-3-gallate from chitosan-based scaffolds to promote osteogenesis of mesenchymal stem cell.
Wang J; Sun Q; Wei Y; Hao M; Tan WS; Cai H
Int J Biol Macromol; 2021 Apr; 176():96-105. PubMed ID: 33577812
[TBL] [Abstract][Full Text] [Related]
78. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
[TBL] [Abstract][Full Text] [Related]
79. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
80. Effect of bioactive dietary polyphenols on zinc transport across the intestinal Caco-2 cell monolayers.
Kim EY; Pai TK; Han O
J Agric Food Chem; 2011 Apr; 59(8):3606-12. PubMed ID: 21410257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
